JP2024540976A5 - - Google Patents
Info
- Publication number
- JP2024540976A5 JP2024540976A5 JP2024523853A JP2024523853A JP2024540976A5 JP 2024540976 A5 JP2024540976 A5 JP 2024540976A5 JP 2024523853 A JP2024523853 A JP 2024523853A JP 2024523853 A JP2024523853 A JP 2024523853A JP 2024540976 A5 JP2024540976 A5 JP 2024540976A5
- Authority
- JP
- Japan
- Prior art keywords
- ivp
- cvb
- protein
- quantities
- polypeptides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163271546P | 2021-10-25 | 2021-10-25 | |
| US63/271,546 | 2021-10-25 | ||
| US202163273723P | 2021-10-29 | 2021-10-29 | |
| US63/273,723 | 2021-10-29 | ||
| US202263321911P | 2022-03-21 | 2022-03-21 | |
| US63/321,911 | 2022-03-21 | ||
| PCT/US2022/078581 WO2023076856A1 (en) | 2021-10-25 | 2022-10-24 | Coxsackievirus b compositions and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024540976A JP2024540976A (ja) | 2024-11-06 |
| JP2024540976A5 true JP2024540976A5 (enExample) | 2025-10-31 |
Family
ID=86158933
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024523853A Pending JP2024540976A (ja) | 2021-10-25 | 2022-10-24 | Ｂ群コクサッキーウイルス組成物およびその使用法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250352634A1 (enExample) |
| EP (1) | EP4422680A4 (enExample) |
| JP (1) | JP2024540976A (enExample) |
| IL (1) | IL312205A (enExample) |
| WO (1) | WO2023076856A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116769733B (zh) * | 2023-08-02 | 2023-11-03 | 中国医学科学院医学生物学研究所 | 一种柯萨奇病毒b组4型毒株及应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2402029A1 (en) * | 2010-07-01 | 2012-01-04 | Sanofi Pasteur | Enterovirus vaccines for preventing or treating type 1 diabetes (III) |
| EP2583688A1 (en) * | 2011-10-18 | 2013-04-24 | Sanofi Pasteur | Multi-CBV vaccine for preventing or treating type 1 diabetes |
-
2022
- 2022-10-24 EP EP22888412.8A patent/EP4422680A4/en active Pending
- 2022-10-24 WO PCT/US2022/078581 patent/WO2023076856A1/en not_active Ceased
- 2022-10-24 US US18/703,256 patent/US20250352634A1/en active Pending
- 2022-10-24 IL IL312205A patent/IL312205A/en unknown
- 2022-10-24 JP JP2024523853A patent/JP2024540976A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Li et al. | SARS-CoV-2 spike produced in insect cells elicits high neutralization titres in non-human primates | |
| Bain et al. | Memory T-cell-mediated immune responses specific to an alternative core protein in hepatitis C virus infection | |
| TWI605124B (zh) | 新穎桿狀病毒載體及使用方法 | |
| CN112043825B (zh) | 一种基于新型冠状病毒突刺蛋白s1区域预防新型冠状病毒感染的亚单位疫苗 | |
| Xu et al. | Occult HBV infection in anti-HBs-positive young adults after neonatal HB vaccination | |
| CN106661102A (zh) | 作为对抗肠病毒感染之免疫原的病毒颗粒及其制造 | |
| CN102399757A (zh) | 免疫原性组合物及其用途 | |
| Akram et al. | Molecular structure, pathogenesis and virology of SARS-CoV-2: A review | |
| CN120459288A (zh) | 融合蛋白疫苗平台的构建与应用 | |
| WO2022252745A1 (zh) | 一种免疫分子病毒颗粒检测试剂盒 | |
| Yu et al. | Recent research advances in the development of Dabie Banda virus vaccines | |
| CN102210861A (zh) | 丙型肝炎病毒多表位肽负荷的树突状细胞治疗性疫苗 | |
| Zhang et al. | Single dose recombinant VSV based vaccine elicits robust and durable neutralizing antibody against Hantaan virus | |
| CN1874787B (zh) | 预防/治疗hbv感染和hbv介导疾病的组合物 | |
| TW201938578A (zh) | 腸病毒疫苗 | |
| Lee et al. | Clinical significance of rhinoviruses and progress toward vaccination | |
| JP2024523329A5 (enExample) | ||
| JP2007504112A5 (enExample) | ||
| Lu et al. | Hepatitis vaccines: Recent advances and challenges | |
| CN106421774A (zh) | PreS1用于制备乙肝疫苗以及治疗慢性乙型肝炎的用途 | |
| RU2639504C2 (ru) | Химерные антигены для вакцины против вируса гепатита с | |
| CN105238767B (zh) | 人3型腺病毒展示人55型腺病毒中和抗原表位疫苗候选株的制备方法和应用 | |
| Lee et al. | Sublingual immunization of trivalent human papillomavirus DNA vaccine in baculovirus nanovector for protection against vaginal challenge | |
| Kimura et al. | Efficient Neutralizing Antibodies Induction by Human Parvovirus B19 Epitope‐Presenting Protein Nanoparticles | |
| CN105238766A (zh) | 人3型腺病毒展示人14型腺病毒中和抗原表位疫苗候选株的制备方法和应用 |